Grimes & Company, Inc. Heron Therapeutics, Inc. Call Options Transaction History
Grimes & Company, Inc.
- $3.66 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HRTX
# of Institutions
190Shares Held
129MCall Options Held
94.7KPut Options Held
148K-
Rubric Capital Management LP New York, NY26.7MShares$47.6 Million2.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.62MShares$15.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$14.8 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.6MShares$13.5 Million0.05% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$12.4 Million58.47% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $211M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...